Publications by authors named "Shu-wen Yu"

Claim this Profile
P
Pro-protein convertase subtilisin/kexin type 9 promotes intestinal tumor development by activating Janus kinase 2/signal transducer and activator of transcription 3/SOCS3 signaling in Apc mice.
Kai Yang, Jie Zhu, Huan-Hua Luo, Shu-Wen Yu, Lu Wang

Int J Immunopathol Pharmacol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myricetin induces apoptosis and autophagy by inhibiting PI3K/Akt/mTOR signalling in human colon cancer cells.
Ming-Liang Zhu, Pei-Min Zhang, Min Jiang, Shu-Wen Yu, Lu Wang

BMC Complement Med Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-treatment with puerarin affects pharmacokinetics of warfarin, but not clopidogrel, in experimental rats.
An-Chang Liu, Li-Xia Zhao, Shu-Wen Yu, Hong-Xiang Lou

Chin J Nat Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Research progress on antitumor effects and mechanisms of phellinus].
Wen-wen Gao, Na Zhang, Shu-wen Yu

Zhongguo Zhong Yao Za Zhi· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury.
Li-xia Zhao, An-chang Liu, Shu-wen Yu, Zeng-xin Wang, Xiao-qian Lin

Biol Pharm Bull· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis